Market Research Logo

Global Guillain-Barré Syndrome Treatment Market 2019-2023

Global Guillain-Barré Syndrome Treatment Market 2019-2023

About this market

The trend of strategic alliances to help market grow at a flourishing rate. Pharmaceutical companies are working together for the development of medications for the treatment of Guillain-Barré syndrome. These alliances will enhance the R&D activities of new drugs for the management of Guillain-Barré syndrome. Technavio’s analysts have predicted that the Guillain-Barré syndrome treatment market will register a CAGR of more than 5% by 2023.

Market Overview

Recent approvals of immunoglobulins

Immunoglobulins are the first line treatment of Guillain-Barré syndrome. The recent approvals of novel immunoglobulins from regulatory bodies are expected to propel the growth of the global Guillain-Barré syndrome treatment market during the forecast period.

Availability of alternate therapies

Currently there is no cure for Guillain-Barré syndrome. The goal of the available treatments is to provide relief from the symptoms of disease. Although the intravenous immunoglobin therapy is more convenient and widely available, it has certain side effects. Hence, some physicians are strongly inclined toward other available plasma exchange procedures for the treatment of Guillain-Barré syndrome.

For the detailed list of factors that will drive and challenge the growth of the Guillain-Barré syndrome treatment market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including CSL and Grifols the competitive environment is quite intense. Factors such as the recent approvals of immunoglobulins and strategic alliances, will provide considerable growth opportunities to Guillain-Barré syndrome treatment manufactures. CSL, Grifols, Octapharma, Shire, and Kedrion are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. The market will witness the emergence of many international and regional GBS treatment companies who offer therapeutics such as immunoglobulins and other therapeutics. Pharmaceutical companies are working together for the development of medications for the treatment of Guillain-Barré syndrome, which is expected to enhance the R&D activities of new drugs for the management of GB syndrome.’


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Guillain-Barré Syndrome Treatment Market 2019-2023

Technavio recognizes the following companies as the key players in the global Guillain-Barré syndrome treatment market: CSL, Grifols, Octapharma, Shire, and Kedrion.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the strong pipeline of immunoglobulins.”

According to the report, one of the major drivers for this market is the recent approvals of immunoglobulins.

Further, the report states that one of the major factors hindering the growth of this market is the availability of alternate therapies.

Companies Mentioned

CSL

Grifols

Kedrion

Octapharma

Shire

  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global neurological disorder drugs market
      • Table Segments of global neurological disorder drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Immunoglobulins - Market size and forecast 2018-2023
      • Table Immunoglobulins - Market size and forecast 2018-2023 ($ millions)
      • Table Immunoglobulins - Year-over-year growth 2019-2023 (%)
    • Other therapeutics - Market size and forecast 2018-2023
      • Table Other therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Other therapeutics - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • CSL
      • Table CSL - Vendor overview
      • Table CSL - Business segments
      • Table CSL - Organizational developments
      • Table CSL - Geographic focus
      • Table CSL - Segment focus
      • Table CSL - Key offerings
      • Table CSL - Key customers
    • Grifols
      • Table Grifols - Vendor overview
      • Table Grifols - Business segments
      • Table Grifols - Organizational developments
      • Table Grifols - Geographic focus
      • Table Grifols - Segment focus
      • Table Grifols - Key offerings
      • Table Grifols - Key customers
    • Kedrion
      • Table Kedrion - Vendor overview
      • Table Kedrion - Business segments
      • Table Kedrion - Organizational developments
      • Table Kedrion - Geographic focus
      • Table Kedrion - Segment focus
      • Table Kedrion - Key offerings
      • Table Kedrion - Key customers
    • Octapharma
      • Table Octapharma - Vendor overview
      • Table Octapharma - Organizational developments
      • Table Octapharma - Key offerings
      • Table Octapharma - Key customers
    • Shire
      • Table Shire - Vendor overview
      • Table Shire - Business segments
      • Table Shire - Organizational developments
      • Table Shire - Geographic focus
      • Table Shire - Key offerings
      • Table Shire - Key customers
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report